I led product design for Mobili-T, a mobile swallowing therapy system for people with dysphagia (the medical term for swallowing impairment).
I was involved from the earliest stages of R&D through to commercialization, leading UI/UX, industrial design, patient-focused research, brand, onboarding and all of the design gaps needed in a Startup.
Mobili-T was adopted by 50+ leading health organizations, including Stanford Medical, Harvard Medical, Kaiser Permanente, Cleveland Clinic, and UCLA Health.
Like physical therapy for a knee injury, swallowing therapy helps patients with dysphagia rebuild the muscle strength needed to eat, drink and speak. The most severe cases of dysphagia are caused by conditions like head and neck cancer or stroke. Dysphagia affects more than 500 million people worldwide, leading to malnutrition, extended hospital stays, and significant psychosocial challenges.
Designed in close collaboration with patients and clinicians, Mobili-T enables remotely monitored therapy that was previously limited to major hospitals. An under-chin sensor (held by a custom adhesive) tracks muscle activity in real time, bringing effective treatment into everyday settings.
Mobili-T began as a research initiative with a $1.9 million contribution from the Alberta Cancer Foundation, focused on improving access to swallowing therapy for people with dysphagia.
I worked closely with clinicians, engineers, researchers, and patients to translate clinical protocols into at-home therapy experiences.
What started as a hospital-based technology, evolved into a portable, sensor-driven system that enables patients to complete therapy remotely while clinicians monitor progress. This work ultimately led to the creation of True Angle Medical Technologies, a spin-off company built to bring Mobili-T to market.
Core77 Design Awards - Research & Strategy and Community Choice for Mobili-T with Dylan Scott
US Patents including:
- Systems and Methods with Gamification
- Diagnosis & Treatment of Swallowing Disorders
Multiple scientific publications including:
- Usability testing of an mHealth device for swallowing therapy in head and neck cancer survivors
- Designing for patients: Using a cultural probe in the development of a mobile health device and application for swallowing therapy in head and neck cancer patients
- Designing a Mobile Health App for Patients With Dysphagia
My design and research contributions helped True Angle secure an oversubscribed $1.64 million funding round as featured on Crunchbase
Our work as a team helped raise $3.4 million in grant funding and $2.5 million in investments
NACO startup of the year in 2021
Clinician knowledge and patient access was invaluable. The fridge sized existing tech was described as cumbersome, costly and non-portable.
I worked extensively with Dr. Gabriela Constantinescu defining learning goals, mapping research methods and patient/clinician UX.
Including patients in the design process was critical to ensure the system was usable, relevant, and grounded in real-world needs, wants and limitations.
Design and engineering synthesis was imperative. My collaborations with CTO Dylan Scott rapidly transformed concepts into reality.
— Ted, Clinical Trial Participant
Living with dysphagia is difficult enough.
Access to treatment shouldn’t add to the burden.
Each year, 1 in 6 adults experiences a swallowing disorder.
It disrupts the most basic human functions: eating, speaking, and social connection.
Surface electromyography (sEMG) is the clinical gold standard for swallowing therapy, using muscle signals to provide real-time feedback.
Traditional systems are large, expensive, and limited to clinical settings. They require (error prone) precise electrode placement under the jaw, and rely on wired connections that can be uncomfortable, prone to dislodgement, and susceptible to signal interference.
We improved access, cost and convenience for an extremely prevalent disorder that is exceptionally underserved.
We did this by immersing ourselves in the lives of patients, the responsibilities of clinicians and the challenges facing administrators when adopting new technologies.
I spent time learning about their needs, wants, motivations and limitations to guide and inspire our multi-disciplinary team. Some of the ways I did this included cultural probes and patient interviews, which are described in more detail in Design Methods.
Mobili-T iOS app and under-chin sEMG hardware that captures muscle activity and provides real-time visual biofeedback in the app
I used Personas to summarize key research findings. This created data-driven, humanized references in our product discussions.
Quantitative data was summarized in digital/print infographics to further faciltate discussions and decisions.
The “Cyclops” symbol maps directly to electrode placement, guiding correct positioning while turning a requirement into a simple, memorable interaction.
In the clinical testing version of the product, I designed the branding element affectionately named “The Cyclops”, to improve electrode placement. The “eye” aligns with the ground electrode which situates at the jawbone, while the “smile” maps to the swallowing muscles.
This visual pattern simplifies placement, addressing a key challenge with traditional sEMG systems, while doubling as a playful, recognizable symbol used across Mobili-T’s product, packaging, and brand.
It brings a sense of warmth and humanity to an experience previously viewed as difficult and intimidating.
Hands-on feedback and user testing shaped the product at every stage - from storyboard walkthroughs to functional testing of both hardware and software.
This ongoing involvement kept the team grounded in the realities patients face every day. It meant making space for those who had lost the ability to speak to still be heard, and scheduling sessions around the demands of treatment.
More than validation, it deepened our empathy and strengthened our commitment to creating a system that meaningfully supports their needs.
Testing and feedback were integral to keeping the team focused on improving access to swallowing therapy. Which meant making sure this could be used at home.
Following clinical testing, Mobili-T underwent numerous changes driven by insights gained from patients, clinicians and administrators.
As Mobili-T moved through R&D and clinical testing into commercialization, improvements were made to the hardware, software and business model.
You can read more details of designing the Mobili-T app here.
You can read about the design of the Clinician Portal here.
You can read about the design of the Onboarding experience here.
And you can read about the conceptualization of a new product offering (Core), here.